Skip to main content
SpringerLink
Log in

Agents in Development for Type 2 Diabetes

  • Section 1: Type 2 Diabete Mellitus
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53

    Article  Google Scholar 

  2. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86

    Article  Google Scholar 

  3. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet Med 1999; 16: 179–92

    Article  PubMed  CAS  Google Scholar 

  4. Plosker GL, Faulds D. Troglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs 1999; 57: 409–38

    Article  PubMed  CAS  Google Scholar 

  5. Owens DR. Repaglinide — prandial glucose regulator: a new class of oral antidiabetic agents. Diabet Med 1998; 15 Suppl. 4: S28–36

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International, Auckland, New Zealand

    Blair Jarvis & Shelley Elkinson

Authors
  1. Blair Jarvis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shelley Elkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jarvis, B., Elkinson, S. Agents in Development for Type 2 Diabetes. Drugs R&D 2, 95–99 (1999). https://doi.org/10.2165/00126839-199902020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902020-00002

Keywords

Search

Navigation